It is known that Bim elevation or induction accounts for a critical mechanism by which EGFR-TKIs including erlotinib and osimertinib induce apoptosis in NSCLC cells with EGFR activating mutations 35, 38-40. This evidence concerns the gene EGFR and non-small cell lung carcinoma.